356 related articles for article (PubMed ID: 29858685)
21. Clinicopathologic, immunophenotypic, and molecular cytogenetic fluorescence in situ hybridization analysis of primary and secondary cutaneous follicular lymphomas.
Kim BK; Surti U; Pandya A; Cohen J; Rabkin MS; Swerdlow SH
Am J Surg Pathol; 2005 Jan; 29(1):69-82. PubMed ID: 15613857
[TBL] [Abstract][Full Text] [Related]
22. Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature.
Miao Y; Hu S; Lu X; Li S; Wang W; Medeiros LJ; Lin P
Hum Pathol; 2016 Dec; 58():72-77. PubMed ID: 27544800
[TBL] [Abstract][Full Text] [Related]
23. Partial lack of BCL2 in follicular lymphoma: An unusual immunohistochemical staining pattern explained by ongoing BCL2 mutation.
van den Brand M; Garcia-Garcia M; Mathijssen JJ; Colomo L; Groenen PJ; Serrano S; van Krieken JH
Pathol Res Pract; 2016 Feb; 212(2):148-50. PubMed ID: 26725534
[TBL] [Abstract][Full Text] [Related]
24. Follicle Center Lymphoma (FCL) of the Lower Female Genital Tract (LFGT): A Novel Variant of Primary Cutaneous Follicle Center Lymphoma (PCFCL).
Saksena A; Jain A; Pack SD; Kim J; Lee I; Tyagi M; Xi L; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2023 Mar; 47(3):409-419. PubMed ID: 36461146
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological features of primary diffuse large B-cell lymphoma of the central nervous system - strong EZH2 expression implying diagnostic and therapeutic implication.
Guo S; Bai Q; Rohr J; Wang Y; Liu Y; Zeng K; Yu K; Zhang X; Wang Z
APMIS; 2016 Dec; 124(12):1054-1062. PubMed ID: 27807891
[TBL] [Abstract][Full Text] [Related]
26. Relative frequency and clinicopathologic characteristics of MYC-rearranged follicular lymphoma.
Chaudhary S; Brown N; Song JY; Yang L; Skrabek P; Nasr MR; Wong JT; Bedell V; Murata-Collins J; Kochan L; Li J; Zhang W; Chan WC; Weisenburger DD; Perry AM
Hum Pathol; 2021 Aug; 114():19-27. PubMed ID: 33964277
[TBL] [Abstract][Full Text] [Related]
27. Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular lymphoma.
Fernandez-Pol S; Bangs CD; Cherry A; Arber DA; Gratzinger D
Hum Pathol; 2016 Sep; 55():39-43. PubMed ID: 27134111
[TBL] [Abstract][Full Text] [Related]
28. Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas.
Martin-Guerrero I; Salaverria I; Burkhardt B; Szczepanowski M; Baudis M; Bens S; de Leval L; Garcia-Orad A; Horn H; Lisfeld J; Pellissery S; Klapper W; Oschlies I; Siebert R
Haematologica; 2013 Aug; 98(8):1237-41. PubMed ID: 23445872
[TBL] [Abstract][Full Text] [Related]
29. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
[TBL] [Abstract][Full Text] [Related]
30. Acquired N-Linked Glycosylation Motifs in B-Cell Receptors of Primary Cutaneous B-Cell Lymphoma and the Normal B-Cell Repertoire.
Koning MT; Quinten E; Zoutman WH; Kiełbasa SM; Mei H; van Bergen CAM; Jansen P; Vergroesen RD; Willemze R; Vermeer MH; Tensen CP; Veelken H
J Invest Dermatol; 2019 Oct; 139(10):2195-2203. PubMed ID: 31042459
[TBL] [Abstract][Full Text] [Related]
31. Profiling of Copy Number Alterations Using Low-Coverage Whole-Genome Sequencing Informs Differential Diagnosis and Prognosis in Primary Cutaneous Follicle Center Lymphoma.
Bátai B; Kiss L; Varga L; Nagy Á; Househam J; Baker AM; László T; Udvari A; Horváth R; Nagy T; Csomor J; Szakonyi J; Schneider T; Graham TA; Alpár D; Fitzgibbon J; Szepesi Á; Bödör C
Mod Pathol; 2024 May; 37(5):100465. PubMed ID: 38460675
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands.
Šteiner P; Andreasen S; Grossmann P; Hauer L; Vaněček T; Miesbauerová M; Santana T; Kiss K; Slouka D; Skálová A
Virchows Arch; 2018 Oct; 473(4):471-480. PubMed ID: 29619555
[TBL] [Abstract][Full Text] [Related]
33. Combined Reverse-Transcriptase Multiplex Ligation-Dependent Probe Amplification and Next-Generation Sequencing Analyses to Assign Unclassified BCL2
Sesboue C; Galtier J; Jeanneau M; Chauvel A; Laharanne E; Amintas S; Merlio JP; Bouabdallah K; Gros FX; de Leval L; Gros A; Parrens M
Mod Pathol; 2023 Feb; 36(2):100043. PubMed ID: 36853790
[TBL] [Abstract][Full Text] [Related]
34. Primary cutaneous follicle center lymphoma with Hodgkin and Reed-Sternberg-like cells: a new histopathologic variant.
Dilly M; Ben-Rejeb H; Vergier B; Feldis M; Toty L; Nohra O; Beylot-Barry M; Gros A; Merlio JP; Parrens M
J Cutan Pathol; 2014 Oct; 41(10):797-801. PubMed ID: 25099172
[TBL] [Abstract][Full Text] [Related]
35. A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36.
Katzenberger T; Kalla J; Leich E; Stöcklein H; Hartmann E; Barnickel S; Wessendorf S; Ott MM; Müller-Hermelink HK; Rosenwald A; Ott G
Blood; 2009 Jan; 113(5):1053-61. PubMed ID: 18978208
[TBL] [Abstract][Full Text] [Related]
36. High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis.
Launay E; Pangault C; Bertrand P; Jardin F; Lamy T; Tilly H; Tarte K; Bastard C; Fest T
Leukemia; 2012 Mar; 26(3):559-62. PubMed ID: 21941365
[No Abstract] [Full Text] [Related]
37. Multiplex sequencing for EZH2, CD79B, and MYD88 mutations using archival cytospin preparations from B-cell non-Hodgkin lymphoma aspirates previously tested for MYC rearrangement and IGH/BCL2 translocation.
Santos Gda C; Saieg MA; Ko HM; Geddie WR; Boerner SL; Craddock KJ; Crump M; Bailey D
Cancer Cytopathol; 2015 Jul; 123(7):413-20. PubMed ID: 25807917
[TBL] [Abstract][Full Text] [Related]
38. Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases.
Mollejo M; Rodríguez-Pinilla MS; Montes-Moreno S; Algara P; Dogan A; Cigudosa JC; Juarez R; Flores T; Forteza J; Arribas A; Piris MA
Am J Surg Pathol; 2009 May; 33(5):730-8. PubMed ID: 19194277
[TBL] [Abstract][Full Text] [Related]
39. The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-"negative" grade 1/2 follicular lymphomas.
Adam P; Baumann R; Schmidt J; Bettio S; Weisel K; Bonzheim I; Fend F; Quintanilla-Martínez L
Hum Pathol; 2013 Sep; 44(9):1817-26. PubMed ID: 23642737
[TBL] [Abstract][Full Text] [Related]
40. Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and/or Bcl6 or p53 expression.
Guo Y; Karube K; Kawano R; Suzumiya J; Takeshita M; Kikuchi M; Huang GS; Li Q; Ohshima K
Pathol Int; 2007 Mar; 57(3):148-52. PubMed ID: 17295647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
